2024年7月6日
827022-35-5,Palbociclib
https://www.watson-int.cn/wp-content/uploads/2024/07/palbociclib-impurity-7.jpg
500
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-06 23:47:50 2024-07-06 23:47:50 Palbociclib Impurity 7 CAS号 827022-35-5 2024年7月6日
2206135-30-8,Palbociclib
https://www.watson-int.cn/wp-content/uploads/2024/07/palbociclib-impurity-10.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-06 23:47:50 2024-07-06 23:47:50 Palbociclib Impurity 10 CAS号 2206135-30-8 2024年7月6日
N/A,Teneligliptin
https://www.watson-int.cn/wp-content/uploads/2024/07/teneligliptin-impurity-g-ditfa-salt.jpg
577
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-06 23:47:50 2024-07-06 23:47:50 Teneligliptin Impurity G DiTFA salt CAS号 N/A 2024年7月6日
N/A,Teneligliptin
https://www.watson-int.cn/wp-content/uploads/2024/07/teneligliptin-dimer-impurity-1.jpg
624
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-06 23:47:50 2024-07-06 23:47:50 Teneligliptin Dimer Impurity 1 CAS号 N/A 2024年7月6日
477600-74-1,Tofacitinib
https://www.watson-int.cn/wp-content/uploads/2024/07/tofacitinib-impurity-m.jpg
510
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-06 23:47:50 2024-07-06 23:47:50 Tofacitinib Impurity M CAS号 477600-74-1 2024年7月6日
1260614-73-0,Tofacitinib
https://www.watson-int.cn/wp-content/uploads/2024/07/tofacitinib-impurity-n.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-06 23:47:50 2024-07-06 23:47:50 Tofacitinib Impurity N CAS号 1260614-73-0 2024年7月6日
1640971-87-4,Tofacitinib
https://www.watson-int.cn/wp-content/uploads/2024/07/tofacitinib-impurity-59.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-06 23:47:50 2024-07-06 23:47:50 Tofacitinib Impurity 2 CAS号 1640971-87-4 2024年7月6日
2028267-73-2,Tofacitinib
https://www.watson-int.cn/wp-content/uploads/2024/07/tofacitinib-n-oxide-impurity-1.jpg
510
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-06 23:47:50 2024-07-06 23:47:50 Tofacitinib N-Oxide Impurity 1 CAS号 2028267-73-2 2024年7月6日
2259288-22-5,Tofacitinib
https://www.watson-int.cn/wp-content/uploads/2024/07/tofacitinib-impurity-23.jpg
624
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-06 23:47:50 2024-07-06 23:47:50 Tofacitinib Impurity 17 CAS号 2259288-22-5 2024年7月6日
269396-59-0,Sitagliptin
https://www.watson-int.cn/wp-content/uploads/2024/07/sitagliptin-impurity-g.jpg
511
1200
great_watson-int
https://www.watson-int.cn/wp-content/uploads/2019/10/new-logo-300x300.jpg
great_watson-int 2024-07-06 23:47:16 2024-07-06 23:47:16 Sitagliptin Impurity G CAS号 269396-59-0
Scroll to top
Scroll to top
Scroll to top